Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @avacta
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @avacta
-
Avacta proslijedio/la je TweetHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
-
Avacta proslijedio/la je Tweet
@gambica members@avacta are exhibiting@MedlabSeries Middle East in Dubai until Thursday, go and visit them on stand Z1.B47pic.twitter.com/6giz6w6kGq
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Avacta proslijedio/la je TweetHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
-
Alastair Smith provides update on AffyXell collaboration and licence agreement.https://hubs.ly/H0mSMF70
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
-
Avacta and Daewoong Agree Collaboration and License Agreement with AffyXell Therapeutics. https://hubs.ly/H0mRMW90 pic.twitter.com/ZI5dLFqSzN
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Avacta proslijedio/la je Tweet
Just posted: Avacta - It Gets Even Better https://www.shareprophets.com/47109
#AVCTHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Malcolm Stacey reiterates his excitement about Avacta Group as a priority penny share that he tipped recently for 2020.https://twitter.com/ShareProphets/status/1222434048712179717 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Avacta proslijedio/la je Tweet
Avacta – Value inflection point
#AVCThttps://cube.investments/avacta-value-inflection-point-avct/ …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Avacta proslijedio/la je Tweet
CEO INTERVIEW: Avacta Group PoC for proprietary new class of anti-cancer therapy - http://bit.ly/37Cstne -
#AVCT@Affimers#affimer#biotherapeutics#cancerimmunotherapies#targetedchemotherapyHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
In this short video, Avacta’s Chief Executive Officer Alastair Smith explains the TMAC® drug conjugate and the recent data from the lead molecule in that programme.https://hubs.ly/H0mMC1d0
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Avacta proslijedio/la je Tweet
Research from finnCap's sector specialists today features:
@avacta (#AVCT),@Sopheon (#SPE) and@LPAGroupPlc (#LPA). More: https://www.finncap.com/news-events/finncap-research-company-notes-28-january-2020 … Register for our research portal:http://researchlibrary.finncap.com Disclaimer:http://finncap.com/disclaimers pic.twitter.com/jlCR45WLrG
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Avacta proslijedio/la je Tweet
MORNING REPORT Tuesday 28th January 2020 With
@AndrewScottTV#stocks#LSE#FTSE100#AIM#proactive#investors#news#business#finance#morning http://www.proactiveinvestors.co.uk pic.twitter.com/gzegAkgEvDHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Successful initial proof-of-concept for a proprietary new class of anti-cancer therapy: Avacta’s first TMAC drug conjugate molecule shown to out-perform avelumab in an animal model.https://hubs.ly/H0mM8R50
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
New paper published in
@fsgbio showcasing the Affimer technology: "Harnessing anti-idiotypic antibody alternatives to advance biotherapeutic pharmacokinetic assays" https://hubs.ly/H0mLgrx0Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Given the high level of interest we experienced during the JP Morgan Healthcare Week, we would certainly agree that immuno-oncology is at the top of large pharma’s priorities and shopping lists.https://hubs.ly/H0mK0pt0
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
In this interview, Avacta CEO Alastair Smith discusses the trading update for the period ended 31 December 2019. https://vimeo.com/386900573 .
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Avacta proslijedio/la je Tweet
Avacta Group
#AVCT has forecasted continued growth into 2020 as the group revealed its order intake and sales pipeline to be ‘the strongest to date’. Read the full announcement here: https://www.voxmarkets.co.uk/articles/avacta-group-sees-strong-revenues-coming-into-2020-c10a201/ …#VoxMarkets#FinancialNews#news#StockMarketNews#BusinessHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
New research on Avacta published by
@finnCap: 'Positive 17-month trading update'.https://avacta.com/investors/research-notes/ …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.